<![CDATA[Pharma — December 2022]]>AbbVie Presents Data For Navitoclax Combination For JAK Inhibitor-Naïve Myelofibrosis Patients https://www.proinvestor.com/investornyt/914628/abbvie-presents-data-for-navitoclax-combination-for-jak-inhibitor-naive-myelofibrosis-patients

]]>https://dev.proinvestor.com/forum/topic/400869/pharma-december-2022RSS for NodeSun, 07 Jun 2026 11:20:20 GMTSun, 11 Dec 2022 04:35:35 GMT60<![CDATA[Reply to Pharma — December 2022 on Sat, 24 Dec 2022 08:20:24 GMT]]>Godformiddag med lidt spændende fra pharma/biotek: "Analysts Say These 2 Stocks Could Double Your Money — Here’s Why They Could Surge"

https://www.proinvestor.com/investornyt/919787/analysts-say-these-2-stocks-could-double-your-money-heres-why-they-could-surge

]]>https://dev.proinvestor.com/forum/post/8037640https://dev.proinvestor.com/forum/post/8037640Sat, 24 Dec 2022 08:20:24 GMT<![CDATA[Reply to Pharma — December 2022 on Tue, 13 Dec 2022 18:22:30 GMT]]>Pfizer sees $10 bln-$15 bln in potential revenue from mRNA vaccines by 2030 (link) For investorer er vacciner lige så interessante som insulin

]]>https://dev.proinvestor.com/forum/post/8037641https://dev.proinvestor.com/forum/post/8037641Tue, 13 Dec 2022 18:22:30 GMT